Free Trial

Silo Pharma (SILO) Institutional Ownership

Silo Pharma logo
$0.45 -0.01 (-2.17%)
Closing price 04:00 PM Eastern
Extended Trading
$0.46 +0.01 (+1.55%)
As of 05:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Silo Pharma (NASDAQ:SILO)

Current
Institutional Ownership
Percentage
5.58%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$1.13M
Number of
Institutional Sellers
(last 12 months)
0
Get SILO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Silo Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

SILO Institutional Buying and Selling by Quarter

Silo Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/28/2026 AdvisorShares Investments LLC663,965$239K0.0%+10.8%4.082%
2/12/2026DRW Securities LLC333,733$113K0.0%N/A2.506%
2/10/2026 AdvisorShares Investments LLC599,507$204K0.0%+64.3%4.501%
2/9/2026Geode Capital Management LLC92,905$32K0.0%+134.6%0.697%
11/17/2025Anson Funds Management LP952,381$657K0.1%N/A7.150%
11/14/2025Virtu Financial LLC107,786$74K0.0%N/A0.809%
11/5/2025 AdvisorShares Investments LLC364,878$252K0.0%+98.0%2.740%
8/4/2025 AdvisorShares Investments LLC184,236$116K0.0%+48.3%4.112%
2/13/2025Renaissance Technologies LLC37,500$33K0.0%-83.5%0.837%
11/20/2024Virtu Financial LLC25,615$28K0.0%-38.8%0.571%
5/11/2023Financial Advocates Investment Management44,507$93K0.0%+196.6%1.408%


SILO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of SILO shares?

During the previous two years, the following institutional investors and hedge funds held shares of Silo Pharma shares: Anson Funds Management LP ($657K), AdvisorShares Investments LLC ($239K), DRW Securities LLC ($113K), Virtu Financial LLC ($74K), and Renaissance Technologies LLC ($33K), Geode Capital Management LLC ($32K).Learn more on Silo Pharma's institutional investors.

What percentage of Silo Pharma's stock is owned by institutional investors?

5.58% of Silo Pharma's stock is owned by institutional investors. Learn more on SILO's institutional investor holdings.

Which institutional investors have been buying Silo Pharma's stock?

The following institutional investors have purchased Silo Pharma's stock in the last 24 months: Anson Funds Management LP ($952.38K), AdvisorShares Investments LLC ($539.73K), DRW Securities LLC ($333.73K), Virtu Financial LLC ($107.79K), and Geode Capital Management LLC ($53.31K).

How much institutional buying is happening at Silo Pharma?

Institutional investors have bought a total of 1,986,938 shares in the last 24 months. This purchase volume represents approximately $1.13M in transactions.



This page (NASDAQ:SILO) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners